Rheumatology
News
Scurvy: A Diagnosis Still Relevant Today
Scurvy can cause mucosal and gastric hemorrhages, and may be linked to poor diet or bariatric surgery.
News
Women’s Risk for Lupus Rises With Greater Intake of Ultraprocessed Foods
The risk for SLE doubled in women with anti–double-stranded DNA antibodies.
Conference Coverage
Trial Confirms Treating Gout Based on Uric Acid Level, Not Symptoms
Basing the treatment of gout on reaching and maintaining target serum uric acid level is already endorsed in guidelines, but a randomized trial...
Conference Coverage
Optimized Hospital Care for Gout Improves Uptake of Urate-Lowering Therapy
Almost all people who received in-hospital treatment for a gout flare were using urate-lowering therapy within 6 months of discharge after a...
Conference Coverage
Semaglutide Trial for Knee Osteoarthritis Shows Improvements in Pain, Physical Function
Results of the STEP 9 study in people with knee osteoarthritis and obesity show that semaglutide not only induced significant weight loss but also...
News
Time to Lung Disease in Patients With Dermatomyositis Subtype Estimated
“Establishing an accurate timeline between MDA5 antibody-positive DM and ILD can promote urgency among dermatologists to evaluate extracutaneous...
News from the FDA/CDC
Second Ustekinumab Biosimilar Gets FDA Approval
The biosimilar is expected to be marketed in the United States on or after February 21, 2025.
Conference Coverage
No Increase in Autoimmune Risk Seen With GLP-1 Receptor Agonists and SGLT2 Inhibitors
Patients with type 2 diabetes prescribed GLP-1 receptor agonists or SGLT2 inhibitors did not have a greater risk of developing autoimmune disease...
News from the FDA/CDC
First Denosumab Biosimilar Approved in Two Different Formulations
Denosumab-bddz was also granted interchangeability status, which allows pharmacists to substitute the biosimilar for the reference product without...
News
How Good are Tools to Screen for Spondyloarthritis in Patients With Psoriasis, Uveitis, IBD?
A comparison of screening tools for SpA in conditions that commonly co-occur with the disease revealed few screening tool options for patients...